-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_technical-brief.pdf
December 01, 2014 - We also extracted data on the citation (first author name, journal, and year of
publication), condition … year 1999),
and MoleMax (Derma Medical Systems; decision year 1999). … RCTs identified in the present technical brief
First Author
UI
Country
year
Study
Objective … RCTs identified in the present technical brief (continued)
First Author
UI
Country
year
Study … RCTs identified in the present technical brief (continued)
First Author
UI
Country
year
Study
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
March 19, 2018 - Nonetheless the overall trend is
increasing (despite year to year
differences in direction and
amount … Further description
as to the domains that led to
downgrading a given outcome are
provided in the … Further description
as to the domains that led to
downgrading a given outcome
within each
intervention … Further description
as to the domains that led to
downgrading a given outcome
within each
intervention … Public reviewer
#1, Anonymous
KQ1c A description of how dosing (frequency
and cumulative dose) differs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-interventions-disposition.pdf
May 26, 2017 - The excluded studies appendix is organized by
year and then alphabetically. … major topic areas were
presented with conclusions and then further in the document, there's
more description … TEP
Reviewer #1
Methods Sensory report: good description of categorization of interventions. … Description of included
studies well done; table 2 provides a good overview of types of studies
included … Discussion/Con
clusion
Finally, ref. 42 is not correct – it is to an RCT protocol by the same
author
-
effectivehealthcare.ahrq.gov/sites/default/files/calcineurin-inhibitor_disposition-comments.pdf
March 15, 2016 - The Symphony Trial
conclusion states The Symphony study showed that at
1 year post transplant a regimen … Based on a 25
year heritage as a pioneer in transplant
immunosuppression, we are sharing the following … Peer Reviewer 3 Introduction Page 3, Lines 27-28: the description of desensitization
regimens should … Peer Reviewer 3 Conclusion A strong and succinct description of the risks and
benefits of the various … We have revised the
Conclusion to include a more
useful description of the risks
and benefits of different
-
effectivehealthcare.ahrq.gov/products/glaucoma-treatment/research-protocol
November 16, 2010 - Description of the Condition
Glaucoma is a leading cause of visual impairment and blindness worldwide … A detailed description of Food and Drug Administration (FDA) approval status, indications, and warnings … anterior synechiae
Systemic allergic reaction
Cardiac arrhythmia
Respiratory problems
Death
Description … Timing
Outcomes will be assessed at 1 year of follow-up and at annual intervals thereafter. … Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651-64.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/pico-1-populations-children-with-infantile-hemangiomas-ihs-interventions-early-referral-comparators-delayed-referral-outcomess-minimization-of-functional-impairment-andor-cosmetic-deformity-pico-2-populations-children-with
November 14, 2013 - Home »
Get Involved »
Nominated Topics »
Topic Suggestion Description … Topic Suggestion Description
Date submitted: November 14, 2013
Download Topic Suggestion … A clinical guideline and evidence based approach is needed within the year. … Other Information About You: (optional)
Please choose a description that best describes your role
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
May 04, 2013 - We have added additional information in the report
concerning this study, both a description of the … Peer Reviewer
#8
General The description of the methods and he genral quality of the writing are … is for many children a dynamic and not a constant state and
the notion of cases lasting more than a year … The author reports both best and worst ear
and we have included both in our summary table. … Grammatical outcomes of 3 & 6
year old children with mild to severe hearing loss.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
August 23, 2012 - Reviewer #2 Introduction Page 1, lm 30 and 41: This reviewer suggests deletion of author names
here … This is noted in the description of the studies. … Abstraction Process, p. 32: Individual studies are identified in the tables
by the last name of the first author … It denotes the year in which participants were
born. … As the author of a
systematic review of this topic a decade ago, it is interesting to me that
this
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/women-hiv_disposition-comments.pdf
November 21, 2016 - However, whether they are the only
group that fits that description (e.g., other groups that
face similar … combination antiretroviral therapy
70% of people living with HIV will be over the age of
50 by the year … to inclusion if the study had
US participants and now the inclusion is based on US
affiliation of author … Inclusion based on US participants
is preferable, as author affiliation can change over
time and many … following to the Limitation
section:
To operationalize this, we limited our search to
at least one author
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
December 20, 2018 - We have added more description surround the context of
the definition in the introduction. … Peer
Reviewer #1
Methods Description of Data synthesis and network MA is clear. … We
add this description to the Methods text under “Data
Synthesis” and each radiographic forest plot … There was no description provided for switching to
frequentist method or justification for random or … Peer
Reviewer #1
Results Page 70: please make sure the description of results to be
accurate and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-expansion_research.pdf
April 01, 2012 - Technical Documentation: Requirements and Design Specification
Author affiliations:
Jeff Brown … Metadata include years of data available, types of data
available by year, key contacts, and special … Effective Health Care Program Research Report Number 37
B-4
Revision Author Date Description
1.3 … Effective Health Care Program Research Report Number 37
B-5
Revision Author Date Description
1.5 … Metadata will include years of data available,
types of data available by year, key contacts, special
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ambulatory-safety_research-protocol.pdf
July 24, 2015 - for the Technical Brief
The Agency for Healthcare Research and Quality (AHRQ) is launching a multi-year … initiative in Fiscal Year 2015 to expand the scientific evidence, strategies, and tools that
are available … Searches will begin with
the year 2000. … dual abstraction of study-level details based on the previous MHCS
review, including intervention description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorder_disposition-comments.pdf
October 19, 2015 - My concern is with the lack
of cultural adaptation done on these EBPs or in any case any description … Sheila Eyberg
was an author on both – see below. … is a co-author,
along with some others – I will try to track it down). … This makes it
especially easy to review the highlights and then target the detailed
description for … We have added the description of
all exclusion codes to the table.
-
effectivehealthcare.ahrq.gov/products/cerebral-palsy-feeding/research-protocol
June 12, 2012 - Data suggest that during the first year of life, 57 percent of children with CP have sucking problems … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, population and intervention descriptions, sample size, key outcomes, and study … Prevalence of cerebral palsy among ten-year-old children in metropolitan Atlanta, 1985 through 1987. … A priori' methods of assessment should be provided (e.g., for effectiveness studies if the author(s)
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
June 07, 2013 - Please
reword to provide a more detailed description
We have revised the sentence to be more precise … primary focus was on the association
between OC use and ovarian cancer, we chose a less
restrictive year … compared to the other cancers of interest,
we analyzed the results with both a more and less
restrictive year … Would it be
possible/helpful to stratify the 0-10 year interval into 2
intervals? … The reviewer is correct, and we have revised this
description to clarify that probabilistic analysis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_disposition-comments.pdf
October 01, 2012 - We have also added this
as a further description of the
heterogeneity in the pain section:
“Moreover … There is no reference provided for this specific
year. … year as 2010). … More description of the studies - including why it is
counted as QI study. … We have clarified in a footnote that the
different author studies are actually
different publications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - Cycle 1 (1st assessment)
In total, 4 CER-specific (e.g., lead author, clinical content experts, and … Based on the study description, we surmised that
most of the adverse events either took place in a … . 319 (32%), p=0.005
Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
Author … 14/61 (23%), p=0.001
Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
Author … PV NA Complications
Source: www.effectivehealthcare.ahrq.gov
Published online: May 16, 2013
Author
-
effectivehealthcare.ahrq.gov/products/distributed-network-safety/research
July 28, 2009 - Technical description. … Technical description. … Technical description. … Technical description. … Technical description.
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
August 01, 2022 - Author
Emily Gean
Conflict of Interest: None of the investigators have any affiliations or financial … The findings and conclusions in this document are those of
the author(s) who are responsible for its … See Appendix B for detailed description of
the criteria. … effectivehealthcare.ahrq.gov/sites/default/files/webform/docs/APBI%202017%20Guidelin
e.pdf
Title or short description … References
Author
Impact of a New Evidence Review
Yes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
January 27, 2014 - Characteristics”
for Key Question 1, we report that “the median age of
patients was between 60 and 70 year … Peer Reviewer#1 Introduction The description needs to be
clarified regarding the clinical
indications … Peer Reviewer#1 Methods There is no description of
whether or not the authors
included grey literature … An explanation of how pain was evaluated is
included in each study description. … than
compression alone, especially
for ulcers that had failed
therapy and were present for
over 1 year